@glitterbag,
Quote: I just wanted to read what ever it was that you read.
Yeah, I've already posted it . . .
Quote:I really shouldn't have asked for clarification, if that's what you believe, then I guess it must be true.
Well now you know that it's not what I believe, but what the CDC said about it when forced to respond to the request for the virus.
Remember this?
The official CDC document, (dated July 21, 2021) entitled “CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel reads as follows:
Since no quantified virus isolates of the 2019-nCoV were available for CDC use at the time the test was developed [January 2020] and this study conducted, assays designed for detection of the 2019-nCoV RNA were tested with characterized stocks of in vitro transcribed full length RNA (N gene; GenBank accession: MN908947.2) of known titer (RNA copies/µL) spiked into a diluent consisting of a suspension of human A549 cells and viral transport medium (VTM) to mimic clinical specimen.
Compare the above statement to the CDC January 28th, 2020 advisory confirming the isolation of SARS-CoV-2:
On January 20, 2020, CDC received a clinical specimen collected from the first reported U.S. patient infected with SARS-CoV-2. CDC immediately placed the specimen into cell culture to grow a sufficient amount of virus for study.
Not based on my belief . . .